{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:56:33Z","timestamp":1790420193963,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003528","name":"Consumers, Health and Food Executive Agency","doi-asserted-by":"publisher","award":["2012-12-14"],"award-info":[{"award-number":["2012-12-14"]}],"id":[{"id":"10.13039\/501100003528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01492"],"award-info":[{"award-number":["PI16\/01492"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01313"],"award-info":[{"award-number":["PI19\/01313"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIBERER","award":["CIBERER-ACCI 2016-03"],"award-info":[{"award-number":["CIBERER-ACCI 2016-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC) was launched to register rare muscle glycogenoses in Europe, to facilitate recruitment for research trials and to learn about the phenotypes and disseminate knowledge about the diseases through workshops and websites. A network of twenty full and collaborating partners from eight European countries and the US contributed data on rare muscle glycogenosis in the EUROMAC registry. After approximately 3\u00a0years of data collection, the data in the registry was analysed.\n<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Of 282 patients with confirmed diagnoses of muscle glycogenosis, 269 had McArdle disease. New phenotypic features of McArdle disease were suggested, including a higher frequency (51.4%) of fixed weakness than reported before, normal CK values in a minority of patients (6.8%), ptosis in 8 patients, body mass index above background population and number of comorbidities with a higher frequency than in the background population (hypothyroidism, coronary heart disease).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The EUROMAC project and registry have provided insight into new phenotypic features of McArdle disease and the variety of co-comorbidities affecting people with McArdle disease. This should lead to better management of these disorders in the future, including controlling weight, and preventive screening for thyroid and coronary artery diseases, as well as physical examination with attention on occurrence of ptosis and fixed muscle weakness. Normal serum creatine kinase in a minority of patients stresses the need to not discard a diagnosis of McArdle disease even though creatine kinase is normal and episodes of myoglobinuria are absent.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13023-020-01562-x","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T22:03:03Z","timestamp":1606255383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)"],"prefix":"10.1186","volume":"15","author":[{"name":"EUROMAC Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata S.","family":"Scalco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Santalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Martinuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinela","family":"Vavla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Reni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlyn V.","family":"Kouwenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lafor\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"San-Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Vieitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"K\u00fchnle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Trost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads G.","family":"Stemmerik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Durmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biruta","family":"Kierdaszuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wakelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni L.","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e0s","family":"Pin\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6144-8544","authenticated-orcid":false,"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"1562_CR1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1177\/0883073813495959","volume":"28","author":"EF Augustine","year":"2013","unstructured":"Augustine EF, Adams HR, Mink JW. Clinical trials in rare disease: challenges and opportunities. J Child Neurol. 2013;28:1142\u201350.","journal-title":"J Child Neurol"},{"key":"1562_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/mus.22130","volume":"44","author":"RA Conwit","year":"2011","unstructured":"Conwit RA, Bhanushali MJ, Porter JD, et al. Adding more muscle and nerve to clinical trials. Muscle Nerve. 2011;44:695\u2013702.","journal-title":"Muscle Nerve"},{"key":"1562_CR3","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.chest.2017.12.018","volume":"153","author":"JK Stoller","year":"2018","unstructured":"Stoller JK. The challenge of rare diseases. Chest. 2018;153:1309\u201314.","journal-title":"Chest"},{"key":"1562_CR4","unstructured":"Orphanet_Report_Series. Rare Diseases Registries in Europe2018 May 2018."},{"key":"1562_CR5","unstructured":"EUROMAC registry of patients with McArdle disease and other rare glycogenolytic disorders with exercise intolerance. www.euromacregistry.eu. Accessed 06\/05\/2018."},{"key":"1562_CR6","unstructured":"Euromac Registry introduction. YouTube 2013. https:\/\/www.youtube.com\/watch?v=NXvmRGLcIy8&list=PLECPX8EZXgfMflBqX4hWLYc4n_4bieuwV."},{"key":"1562_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13023-020-01455-z","volume":"15","author":"T Pin\u00f3s","year":"2020","unstructured":"Pin\u00f3s T, Andreu AL, Bruno C, Hadjigeorgiou GM, Haller RG, Lafor\u00eat P, Luc\u00eda A, Mart\u00edn MA, Martinuzzi A, Navarro C, Oflazer P, Pouget J, Quinlivan R, Sacconi S, Scalco R, Toscano A, Vissing J, Vorgerd M, Wakelin A, Mart\u00ed R, EUROMAC Consortium. Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC Registry). Orphanet J Rare Dis. 2020;15:187. https:\/\/doi.org\/10.1186\/s13023-020-01455-z.","journal-title":"Orphanet J Rare Dis."},{"key":"1562_CR8","unstructured":"AGSD-UK. Association for Glycogen Storage Disease (UK). https:\/\/www.agsd.org.uk. Accessed 20\/06\/2016."},{"key":"1562_CR9","unstructured":"EUROMAC teaching course: diagnosis and management of McArdle disease and rare muscle glycogenoses. https:\/\/www.euromacregistry.eu\/portal1\/content.asp?contentid=1221&c=EUROMAC%20TEACHING%20COURSE. Accessed 05\/05\/2018."},{"key":"1562_CR10","doi-asserted-by":"publisher","first-page":"S220","DOI":"10.1016\/j.nmd.2015.06.132","volume":"25","author":"R Scalco","year":"2015","unstructured":"Scalco R, Vissing C, Godfrey R, Chatfield S, L\u00f8kken N, Madsen K, Pattni J, Michalak Z, Sewry C, Fox Z, McKenna G, Samandouras G, Holton J, Howell J, Haller R, Vissing J, Quinlivan R. Sodium valproate for McArdle disease (glycogen storage disease type V - GSDV). Neuromuscul Disord. 2015;25:S220\u20131.","journal-title":"Neuromuscul Disord"},{"key":"1562_CR11","unstructured":"Scalco RS. Translational research studies in exercise-related muscle disorders. PhD thesis. UCL, London: University College London, 2018."},{"key":"1562_CR12","unstructured":"ClinicalTrials.gov. Fat and sugar metabolism during exercise in patients with metabolic myopathy. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02635269?cond=beta+enolase&rank=1. Accessed 08\/10\/2018."},{"issue":"1","key":"1562_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40478-019-0815-2","volume":"7","author":"P Lafor\u00eat","year":"2019","unstructured":"Lafor\u00eat P, Inoue M, Goillot E, Lefeuvre C, Cagin U, Streichenberger N, Leonard-Louis S, Brochier G, Madelaine A, Labasse C, Hedberg-Oldfors C, Krag T, Jauze L, Fabregue J, Labrune P, Milisenda J, Nadaj-Pakleza A, Sacconi S, Mingozzi F, Ronzitti G, Petit F, Schoser B, Oldfors A, Vissing J, Romero NB, Nichino I, Malfatti E. Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment. Acta Neuropathol Commun. 2019;7(1):167. https:\/\/doi.org\/10.1186\/s40478-019-0815-2.","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"1562_CR14","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/acn3.50863","volume":"6","author":"KL Madsen","year":"2019","unstructured":"Madsen KL, Lafor\u00eat P, Buch AE, Stemmerik MG, Ottolenghi C, Hatem SN, Raaschou-Pedersen DT, Poulsen NS, Atencio M, Luton MP, Ceccaldi A, Haller RG, Quinlivan R, Mochel F, Vissing J. No effect of triheptanoin on exercise performance in McArdle disease. Ann Clin Transl Neurol. 2019;6(10):1949\u201360.","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"1562_CR15","doi-asserted-by":"publisher","first-page":"e1077","DOI":"10.1212\/WNL.0000000000006165","volume":"91","author":"J Vissing","year":"2018","unstructured":"Vissing J, Akman HO, Aasly J, Kahler SG, Bacino CA, DiMauro S, Haller RG. Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiency. Neurology. 2018;91(11):e1077\u201382.","journal-title":"Neurology"},{"issue":"24","key":"1562_CR16","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1212\/WNL.0000000000004752","volume":"89","author":"MG Stemmerik","year":"2017","unstructured":"Stemmerik MG, Madsen KL, Lafor\u00eat P, Buch AE, Vissing J. Muscle glycogen synthesis and breakdown are both impaired in glycogenin-1 deficiency. Neurology. 2017;89(24):2491\u20134.","journal-title":"Neurology"},{"issue":"4","key":"1562_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.nmd.2017.01.014","volume":"27","author":"NC Voermans","year":"2017","unstructured":"Voermans NC, Preisler N, Madsen KL, Janssen MC, Kusters B, Abu Bakar N, Conte F, Lamberti VM, Nusman F, van Engelen BG, van Scherpenzeel M, Vissing J, Lefeber DJ. PGM1 deficiency: substrate use during exercise and effect of treatment with galactose. Neuromuscul Disord. 2017;27(4):370\u20136.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1562_CR18","doi-asserted-by":"publisher","first-page":"R307","DOI":"10.1152\/ajpregu.00489.2015","volume":"311","author":"TO Krag","year":"2016","unstructured":"Krag TO, Pin\u00f3s T, Nielsen TL, Duran J, Garc\u00eda-Rocha M, Andreu AL, Vissing J. Differential glucose metabolism in mice and humans affected by McArdle disease. Am J Physiol Reg Int Comp. 2016;311(2):R307\u201314.","journal-title":"Am J Physiol Reg Int Comp"},{"issue":"5","key":"1562_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/jnen\/nlw018","volume":"75","author":"TO Krag","year":"2016","unstructured":"Krag TO, Pin\u00f3s T, Nielsen TL, Brull A, Andreu AL, Vissing J. Differential muscle involvement in mice and humans affected by McArdle disease. J Neuropathol Exp Neurol. 2016;75(5):441\u201354.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"1562_CR20","doi-asserted-by":"publisher","first-page":"E1096","DOI":"10.1210\/jc.2015-1339","volume":"100","author":"MC \u00d8rngreen","year":"2015","unstructured":"\u00d8rngreen MC, Jeppesen TD, Taivassalo T, Hauerslev S, Preisler N, Heinecke K, Haller RG, Vissing J, van Hall G. Lactate and energy metabolism during exercise in patients with blocked glycogenolysis (McArdle disease). J Clin Endocrinol Metab. 2015;100(8):E1096\u2013104.","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"1562_CR21","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1212\/WNL.0000000000001518","volume":"84","author":"N Preisler","year":"2015","unstructured":"Preisler N, Laforet P, Madsen KL, Prahm KP, Hedermann G, Vissing CR, Galbo H, Vissing J. Skeletal muscle metabolism is impaired during exercise in glycogen storage disease type III. Neurology. 2015;84(17):1767\u201371.","journal-title":"Neurology"},{"key":"1562_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.nmd.2017.04.013","volume":"27","author":"RS Scalco","year":"2017","unstructured":"Scalco RS, Morrow JM, Booth S, Chatfield S, Godfrey R, Quinlivan R. Misdiagnosis is an important factor for diagnostic delay in McArdle disease. Neuromuscul Disord. 2017;27:852\u20135.","journal-title":"Neuromuscul Disord"},{"key":"1562_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1136\/jnnp.2009.195040","volume":"81","author":"R Quinlivan","year":"2010","unstructured":"Quinlivan R, Buckley J, James M, Twist A, Ball S, Duno M, Vissing J, Bruno C, Cassandrini D, Roberts M, Winer J, Rose M, Sewry C. McArdle disease: a clinical review. J Neurol Neurosurg Psych. 2010;81:1182\u20138.","journal-title":"J Neurol Neurosurg Psych"},{"key":"1562_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1186\/s12864-017-4188-2","volume":"18","author":"A Santalla","year":"2017","unstructured":"Santalla A, Nogales-Gadea G, Encinar AB, Vieitez I, Gonz\u00e1lez-Quintana A, Serrano-Lorenzo P, Consuegra IG, Asensio S, Ballester-Lopez A, Pintos-Morell G, Coll-Cant\u00ed J, Pareja-Galeano H, D\u00edez-Bermejo J, P\u00e9rez M, Andreu AL, Pin\u00f3s T, Arenas J, Mart\u00edn MA, Lucia A. Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update. BMC Genomics. 2017;18:819.","journal-title":"BMC Genomics"},{"key":"1562_CR25","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/hast.882","volume":"48","author":"J Michelson","year":"2018","unstructured":"Michelson J. My diagnostic odyssey\u2014a call to expand access to genomic testing for the next generation. The Hastings Center Report. 2018;48:S32\u20134.","journal-title":"The Hastings Center Report"},{"issue":"3","key":"1562_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mus.21351","volume":"40","author":"AA Nadaj-Pakleza","year":"2009","unstructured":"Nadaj-Pakleza AA, Vincitorio CM, Lafor\u00eat P, Eymard B, Dion E, Teijeira S, Vietez I, Jeanpierre M, Navarro C, Stojkovic T. Permanent muscle weakness in McArdle disease. Muscle Nerve. 2009;40(3):350\u20137.","journal-title":"Muscle Nerve"},{"issue":"6","key":"1562_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3928\/01913913-20140813-01","volume":"51","author":"SG Prakalapakorn","year":"2014","unstructured":"Prakalapakorn SG, Proia AD, Yanovitch TL, DeArmey S, Mendelsohn NJ, Aleck KA, Kishnani PS. Ocular and histologic findings in a series of children with infantile Pompe disease treated with enzyme replacement therapy. J Pediatr Ophthal Strab. 2014;51(6):355\u201362.","journal-title":"J Pediatr Ophthal Strab"},{"key":"1562_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1750-1172-8-182","volume":"8","author":"SC Wens","year":"2013","unstructured":"Wens SC, van Gelder CM, Kruijshaar ME, de Vries JM, van der Beek NA, Reuser AJ, van Doorn PA, van der Ploeg AT, Brusse E. Phenotypical variation within 22 families with Pompe disease. Orphanet J Rare Dis. 2013;8:182. https:\/\/doi.org\/10.1186\/1750-1172-8-182.","journal-title":"Orphanet J Rare Dis"},{"key":"1562_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, Okosieme OE, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nature Rev Endocrinol. 2018;14:301\u201316.","journal-title":"Nature Rev Endocrinol"},{"issue":"2","key":"1562_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ophtha.2018.09.013","volume":"126","author":"OA Mahroo","year":"2019","unstructured":"Mahroo OA, Khan KN, Wright G, Ockrim Z, Scalco RS, Robson AG, Tufail A, Michaelides M, Quinlivan R, Webster AR. Retinopathy associated with bi-allelic mutations in PYGM (McArdle disease). Ophthalmology. 2019;126(2):320\u20132.","journal-title":"Ophthalmology"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01562-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T22:03:58Z","timestamp":1606255438000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01562-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1562"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01562-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The project was approved by the Institutional Review Board of the Coordinating Center (Vall d\u2019Hebron Research Institute, Barcelona), and by review boards of each institution recruiting participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"330"}}